Stereospezifität der neuroleptischen Wirkung und Chiralität von (+)-3-{2-[4-(8-Fluor-2-methyl-10,11-dihydrodibenzo[b,f]thiepin-10-yl)-1-piperazinyl]-äthyl}-2-oxazolidinon (16). 4. Mitteilung über tricyclische Antidepressiva und Neuroleptica
摘要:
Stereospecifity of the neuroleptic activity and chirality of (+)‐3‐{2‐[4‐(8‐fluoro‐2‐methyl‐10, 11‐dihydrodibenzo[b,f]thiepin‐10‐yl)‐1‐piperazinyl]ethyl}‐2‐oxazolidinone (16).The synthesis and stereospecific neuroleptic action in animals of the (+)‐enantiomer of 3‐{2‐[4‐(8‐fluoro‐2‐methyl‐10,11‐dihydrodibenzo [b,f]thiepin‐10‐yl)‐1‐piperazinyl]ethyl}‐2‐oxazolidinone (16) are briefly described. The (10S)‐configuration of this compound was determined by X‐ray diffraction.
Stereospezifität der neuroleptischen Wirkung und Chiralität von (+)-3-{2-[4-(8-Fluor-2-methyl-10,11-dihydrodibenzo[b,f]thiepin-10-yl)-1-piperazinyl]-äthyl}-2-oxazolidinon (16). 4. Mitteilung über tricyclische Antidepressiva und Neuroleptica
摘要:
Stereospecifity of the neuroleptic activity and chirality of (+)‐3‐{2‐[4‐(8‐fluoro‐2‐methyl‐10, 11‐dihydrodibenzo[b,f]thiepin‐10‐yl)‐1‐piperazinyl]ethyl}‐2‐oxazolidinone (16).The synthesis and stereospecific neuroleptic action in animals of the (+)‐enantiomer of 3‐{2‐[4‐(8‐fluoro‐2‐methyl‐10,11‐dihydrodibenzo [b,f]thiepin‐10‐yl)‐1‐piperazinyl]ethyl}‐2‐oxazolidinone (16) are briefly described. The (10S)‐configuration of this compound was determined by X‐ray diffraction.
Dibenzothiepin derivatives of the general formula ##STR1## wherein m, n, R.sub.1, R.sub.2, R.sub.3 and X are as hereinafter set forth, And salts thereof as well as processes for their manufacture are disclosed. The end products are useful as central-depressant and neuroleptic agents.
Dibenzothiepin derivatives of the general formula ##STR1## wherein m, n, R.sub.1, R.sub.2, R.sub.3 and X are as hereinafter set forth, and salts thereof as well as processes for their manufacture are disclosed. The end products are useful as central-depressant and neuroleptic agents.